These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 1845764)
1. Compartmental analysis of diprenorphine binding to opiate receptors in the rat in vivo and its comparison with equilibrium data in vitro. Cunningham VJ; Hume SP; Price GR; Ahier RG; Cremer JE; Jones AK J Cereb Blood Flow Metab; 1991 Jan; 11(1):1-9. PubMed ID: 1845764 [TBL] [Abstract][Full Text] [Related]
2. Regional brain measurement of Bmax and KD with the opiate antagonist cyclofoxy: equilibrium studies in the conscious rat. Kawai R; Carson RE; Dunn B; Newman AH; Rice KC; Blasberg RG J Cereb Blood Flow Metab; 1991 Jul; 11(4):529-44. PubMed ID: 1646826 [TBL] [Abstract][Full Text] [Related]
3. Kinetic analysis of transport and opioid receptor binding of [3H](-)-cyclofoxy in rat brain in vivo: implications for human studies. Sawada Y; Kawai R; McManaway M; Otsuki H; Rice KC; Patlak CS; Blasberg RG J Cereb Blood Flow Metab; 1991 Mar; 11(2):183-203. PubMed ID: 1847702 [TBL] [Abstract][Full Text] [Related]
4. Quantification of human opiate receptor concentration and affinity using high and low specific activity [11C]diprenorphine and positron emission tomography. Sadzot B; Price JC; Mayberg HS; Douglass KH; Dannals RF; Lever JR; Ravert HT; Wilson AA; Wagner HN; Feldman MA J Cereb Blood Flow Metab; 1991 Mar; 11(2):204-19. PubMed ID: 1847703 [TBL] [Abstract][Full Text] [Related]
5. Kinetic analysis of 3-quinuclidinyl 4-[125I]iodobenzilate transport and specific binding to muscarinic acetylcholine receptor in rat brain in vivo: implications for human studies. Sawada Y; Hiraga S; Francis B; Patlak C; Pettigrew K; Ito K; Owens E; Gibson R; Reba R; Eckelman W J Cereb Blood Flow Metab; 1990 Nov; 10(6):781-807. PubMed ID: 2134838 [TBL] [Abstract][Full Text] [Related]
6. Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment. Tao PL; Law PY; Loh HH J Pharmacol Exp Ther; 1987 Mar; 240(3):809-16. PubMed ID: 3031275 [TBL] [Abstract][Full Text] [Related]
7. Discrimination of three types of opioid binding sites in rat brain in vivo. Rosenbaum JS; Holford NH; Richards ML; Aman RA; Sadée W Mol Pharmacol; 1984 Mar; 25(2):242-8. PubMed ID: 6321946 [TBL] [Abstract][Full Text] [Related]
8. In vivo opioid receptor occupation in the rat brain following exercise. Sforzo GA; Seeger TF; Pert CB; Pert A; Dotson CO Med Sci Sports Exerc; 1986 Aug; 18(4):380-4. PubMed ID: 3018423 [TBL] [Abstract][Full Text] [Related]
9. Buprenorphine: differential interaction with opiate receptor subtypes in vivo. Sadée W; Rosenbaum JS; Herz A J Pharmacol Exp Ther; 1982 Oct; 223(1):157-62. PubMed ID: 6288917 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of [3H]-buprenorphine in the rat. Holland MJ; Carr KD; Simon EJ Res Commun Chem Pathol Pharmacol; 1989 Apr; 64(1):3-16. PubMed ID: 2546225 [TBL] [Abstract][Full Text] [Related]
11. [3H]diprenorphine receptor binding in vivo and in vitro. Sadée W; Perry DC; Rosenbaum JS; Herz A Eur J Pharmacol; 1982 Jul; 81(3):431-40. PubMed ID: 6288412 [TBL] [Abstract][Full Text] [Related]
12. [3H]-[H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2] ([3H]CTOP), a potent and highly selective peptide for mu opioid receptors in rat brain. Hawkins KN; Knapp RJ; Lui GK; Gulya K; Kazmierski W; Wan YP; Pelton JT; Hruby VJ; Yamamura HI J Pharmacol Exp Ther; 1989 Jan; 248(1):73-80. PubMed ID: 2563293 [TBL] [Abstract][Full Text] [Related]
13. 3H-diprenorphine is selective for mu opiate receptors in vivo. Frost JJ; Smith AC; Wagner HN Life Sci; 1986 Apr; 38(17):1597-606. PubMed ID: 3010021 [TBL] [Abstract][Full Text] [Related]
14. Paradoxical and subtype-specific effects of opiate antagonists on the expression of opioid receptors in rat brain cultures. Barg J; Levy R; Simantov R J Neurosci Res; 1989 Mar; 22(3):322-30. PubMed ID: 2540341 [TBL] [Abstract][Full Text] [Related]
15. Multiple agonist-affinity states of opioid receptors: regulation of binding by guanyl nucleotides in guinea pig cortical, NG108-15, and 7315c cell membranes. Werling LL; Puttfarcken PS; Cox BM Mol Pharmacol; 1988 Apr; 33(4):423-31. PubMed ID: 2833686 [TBL] [Abstract][Full Text] [Related]
17. Study of the density of opioid receptors in the male mouse brain at different stages of sexual maturation. Gutiérrez M; Menéndez L; Hidalgo A; Baamonde A Methods Find Exp Clin Pharmacol; 1999 Sep; 21(7):459-62. PubMed ID: 10544387 [TBL] [Abstract][Full Text] [Related]
18. Comparison of [11C]diprenorphine and [11C]carfentanil binding to opiate receptors in humans by positron emission tomography. Frost JJ; Mayberg HS; Sadzot B; Dannals RF; Lever JR; Ravert HT; Wilson AA; Wagner HN; Links JM J Cereb Blood Flow Metab; 1990 Jul; 10(4):484-92. PubMed ID: 2161414 [TBL] [Abstract][Full Text] [Related]
19. Stimulus induced feeding alters regional opiate receptor binding in the rat: an in vivo audioradiographic study. Stein EA; Carr KD; Simon EJ Prog Clin Biol Res; 1990; 328():187-90. PubMed ID: 2154778 [No Abstract] [Full Text] [Related]
20. Quantitative film autoradiography of opiate agonist and antagonist binding in rat brain. Geary WA; Wooten GF J Pharmacol Exp Ther; 1983 Apr; 225(1):234-40. PubMed ID: 6300375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]